Koers Chalice Brands Ltd. Canadian Securities Exchange
Aandelen
CHAL
CA15756R1047
Farmaceutische producten
Omzet 2019 | 15,75 mln. 21,65 mln. 14,72 mln. | Omzet 2020 | 21,91 mln. 30,11 mln. 20,47 mln. | Marktkapitalisatie | 20,07 mln. 27,58 mln. 18,76 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2019 | -46 mln. -63,21 mln. -42,99 mln. | Nettowinst (verlies) 2020 | -10 mln. -13,74 mln. -9,34 mln. | EV/omzet 2019 | 1,28 x |
Nettoschuld 2019 | 6,22 mln. 8,55 mln. 5,81 mln. | Nettoschuld 2020 | 10,27 mln. 14,11 mln. 9,6 mln. | EV/omzet 2020 | 1,38 x |
K/w-verhouding 2019 |
-0,23
x | K/w-verhouding 2020 |
-1,89
x | Werknemers | - |
Dividendrendement 2019 * |
-
| Dividendrendement 2020 |
-
| Vrij verhandelbaar | 78,85% |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+32,48% | 5,8 mld. | |
-26,22% | 3,92 mld. | |
+4,73% | 3,28 mld. | |
-20,86% | 2,77 mld. | |
-11,88% | 2,26 mld. | |
+46,64% | 1,95 mld. | |
-16,71% | 1,52 mld. | |
+44,65% | 1,49 mld. | |
-9,60% | 1,49 mld. |